Actuate Therapeutics, Inc. Common stock
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACTU | ATNM | APVO | TPST | PCSA | APRE | |
|---|---|---|---|---|---|---|
| Market cap | 20.34M | 44.33M | 2.90M | 9.26M | 5.41M | 6.36M |
| P/E (TTM) | — | 3.9 | 0.0 | — | — | — |
| Forward P/E | -0.6 | -2.7 | -0.1 | -0.4 | -0.5 | -1.3 |
| Price/book | 9.0 | 1.5 | 0.3 | -6.8 | -17.0 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −94.06% | +4.48% | −94.72% | −95.29% | −77.18% | −60.75% |
| Today | +5.69% | +0.71% | +0.74% | −1.13% | −0.26% | −1.90% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ACTU news ›Actuate Therapeutics prices $11M public offering of stock and warrants
Actuate Therapeutics prices an $11M public offering with warrants. Actuate Therapeutics (ACTU) announced Tuesday the pricing of an underwritten public offering of 30.98M shares of its common stock and warrants to purchase up to an…
Actuate Therapeutics proposes 65M-share offering
Bios Entities and Kairos Entities agreed to two-year transfer limits, subject to exceptions, in exchange for warrants Actuate would issue if the offering closes. If the offering closes, Actuate has agreed to issue the Bios and Kairos…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.